Dense breasts: A review of reporting legislation and available supplemental screening options

American Journal of Roentgenology

Volumn 203, Issue 2, 2014, Pages 449-456

  Ho, Jessica M ^a   Jafferjee, Nasima ^a   Covarrubias, Gabriel M ^b   Ghesani, Munir ^a   Handler, Bradley ^a  

^a ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^b Department of Medicine   (United States)

Author keywords

Breast cancer; Breast density; Legislation; Screening; Ultrasound

Indexed keywords

BREAST CANCER; BREAST DENSITY; LEGISLATION; SCREENING; ULTRASOUND;

BREAST; BREAST NEOPLASMS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MAMMOGRAPHY; MASS SCREENING; POSITRON-EMISSION TOMOGRAPHY; RADIATION DOSAGE; RADIOGRAPHIC IMAGE ENHANCEMENT; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY, MAMMARY;

EID: 84906515236     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.13.11969     Document Type: Review

References (52)

1. Swedish Organised Service Screening Evaluation Group. Reduction in breast cancer mortality from organized service screening with mammography: further confirmation with extended data. Cancer Epidemiol Biomarkers Prev 2006; 15:45-51
2. Tabár L, Vitak B, Chen HH, Yen MF, Duffy SW, Smith RA. Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality. Cancer 2001; 91:1724-1731 (Pubitemid 32377958)
3. Tabár L, Yen MF, Vitak B, Chen HH, Smith RA, Duffy SW. Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening. Lancet 2003; 36:1405-1410 (Pubitemid 36515039)
4. U.S. Food and Drug Administration website. Mammography Quality Standards Act (MQSA). www.fda.gov/Radiation-EmittingProducts/ MammographyQualityStandardsActandProgram/Regulations/ucm110823.htm. Updated December 3, 2012. Accessed April 10, 2014
5. Boyd NF, Guo H, Martin LJ, et al. Mammographic density and the risk and detection of breast cancer. N Engl J Med 2007; 356:227-236 (Pubitemid 46143226)
6. Maskarinec G, Pagano I, Lurie G, Kolonel LN. A longitudinal investigation of mammographic density: the multiethnic cohort. Cancer Epidemiol Biomarkers Prev 2006; 15:732-739
7. Byrne C, Schairer C, Wolfe J, et al. Mammography features and breast cancer risk: effects with time, age, and menopause status. J Natl Cancer Inst 1995; 87:1622-1629
8. Yaghjyan L, Colditz GA, Rosner B, Tamimi RM. Mammographic breast density and cancer risk by menopausal status, postmenopausal hormone use and family history of breast cancer. Cancer Causes Control 2012; 23:785-790
9. Vachon CM, van Gils CH, Sellers TA, et al. Mammographic density, breast cancer risk and risk prediction. Breast Cancer Res 2007; 9:217
10. D'Orsi CJ, Bassett LW, Berg WA, et al. BI-RADS: mammography, 4th ed. In: D'Orsi CJ, Mendelson EB, Ikeda DM, et al. Breast Imaging Reporting and Data System: ACR BI-RADS-breast imaging atlas. Reston, VA: American College of Radiology, 2003
11. American College of Radiology website. Breast density: breast cancer screening. www.acr.org/News-Publications/~/media/ 180321AF51AF4EA38FEC091461F5B695.pdf. Accessed April 10, 2014
12. Redondo A, Comas M, Macia F, et al. Inter- and intraradiologist variability in the BI-RADS assessment and breast density categories for screening mammograms. Br J Radiol 2012; 85:1465-1470
13. Bernardi D, Pellegrini M, Di Michele S, et al. Interobserver agreement in breast radiological density attribution according to BI-RADS quantitative classification. Radiol Med (Torino) 2012; 117:519-528
14. Ciatto S, Bernardi D, Calabrese M, et al. A first evaluation of breast radiological density assessment by QUANTRA software as compared to visual classification. Breast 2012; 21:503-506
15. Gweon HM, Youk JH, Kim J, Son EJ. Radiologist assessment of breast density by BI-RADS categories versus fully automated volumetric assessment. AJR 2013; 201:692-697
16. Vachon CM, Brandt KR, Ghosh K, et al. Mammographic breast density as a general marker of breast cancer risk. Cancer Epidemiol Biomarkers Prev 2007; 16:43-49 (Pubitemid 46174262)
17. Berg WA, Blume JD, Cormack JB, et al. Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. JAMA 2008; 299:2151-2163 (Pubitemid 351679706)
18. Berg WA, Zhang Z, Lehrer D, et al.; ACRIN 6666 Investigators. Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk. JAMA 2012; 307:1394-1404
19. Kolb TM, Lichy J, Newhouse JH. Occult cancer in women with dense breasts: detection with screening US - diagnostic yield and tumor characteristics. Radiology 1998; 207:191-199
20. Corsetti V, Ferrari A, Ghirardi M, et al. Role of ultrasonography in detecting mammographically occult breast carcinoma in women with dense breasts. Radiol Med (Torino) 2006; 111:440-448
21. Hooley RJ, Greenberg KL, Stackhouse RM, Geisel JL, Butler RS, Philpotts LE. Screening US in patients with mammographically dense breasts: initial experience with Connecticut Public Act 09-41. Radiology 2012; 265:59-69
22. U.S. Food and Drug Administration website. Medical devices: somo-v Automated Breast Ultrasound System (ABUS) - P110006. www.fda.gov/MedicalDevices/ ProductsandMedicalProcedures/DeviceApprovalsandClearances/Recently- ApprovedDevices/ucm320724.htm. Updated January 17, 2014. Accessed April 10, 2014
23. Drukker K, Horsch KJ, Pesce LL, Giger ML. Interreader scoring variability in an observer study using dual-modality imaging for breast cancer detection in women with dense breasts. Acad Radiol 2013; 20:847-853
24. U-Systems website. Somo-Insight clinical study. u-systems.com/women/somo- insight-clinical-study. Published 2013. Accessed April 10, 2014
25. Kelly KM, Dean J, Comulada WS, Lee SJ. Breast cancer detection using automated whole breast ultrasound and mammography in radiographically dense breasts. Eur Radiol 2010; 20:734-742
26. Chang JM, Moon WK, Cho N, Park JS, Kim SJ. Breast cancers initially detected by hand-held ultrasound: detection performance of radiologists using automated breast ultrasound data. Acta Radiol 2011; 52:8-14
27. Hooley RJ, Scoutt LM, Philpotts LE. Breast ultrasonography: state of the art. Radiology 2013; 268:642-659
28. Kuhl C, Weigel S, Schrading S, et al. Prospective multicenter cohort study to refine management recommendations for women at elevated familial risk of breast cancer: the EVA trial. J Clin Oncol 2010; 28:1450-1457
29. Kuhl CK, Schrading S, Keutner CC, et al. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol 2005; 23:8469-8476
30. Lehman CD, Isaacs C, Schnall MD, et al. Cancer yield of mammography, MR, and US in high-risk women. Radiology 2007; 244:381-388
31. Warner E, Plewes DB, Shumak RS, et al. Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancer. J Clin Oncol 2001; 19:3524-3531 (Pubitemid 32730090)
32. Mainiero MB, Lourenco A, Mahoney MC, et al. ACR appropriateness criteria breast cancer screening. J Am Coll Radiol 2013; 10:11-14
33. Saslow D, Boetes C, Burke W, et al. American Cancer Society guidelines for breast cancer screening with MRI as an adjunct to mammography. CA Cancer J Clin 2007; 57:75-89 (Pubitemid 46535708)
34. Park JM, Franken EA, Garg M, Fajardo LL, Niklason LT. Breast tomosynthesis: present considerations and future applications. RadioGraphics 2007; 27(suppl 1):S231-S240
35. Helvie MA. Digital mammography imaging: breast tomosynthesis and advanced applications. Radiol Clin North Am 2010; 48:917-929
36. Haas BM, Kalra V, Geisel J, Raghu M, Durand M, Philpotts LE. Comparison of tomosynthesis plus digital mammography and digital mammography alone for breast cancer screening. Radiology 2013; 269:694-700
37. Gur D, Abrams GS, Chough DM, et al. Digital breast tomosynthesis: an observer performance study. AJR 2009; 193:586-591
38. Svahn TM, Chakraborty DP, Ikeda D, et al. Breast tomosynthesis and digital mammography: a comparison of diagnostic accuracy. Br J Radiol 2012; 85:e1074-e1082
39. Adler DD, Wahl RL. New methods for imaging the breast: techniques, findings, and potential. AJR 1995; 164:19-30
40. Khalkhali I, Mena I, Jouanne E, et al. Prone scintimammography in patients with suspicion of carcinoma of the breast. J Am Coll Surg 1994; 178:491-497 (Pubitemid 24141506)
41. 99mTc sestamibi and other conventional radiopharmaceuticals in breast cancer diagnosis. Semin Nucl Med 1999; 29:16-40
42. 99mTc- sestamibi breast imaging for the examination of patients with dense and fatty breasts: multicenter study. Radiology 2002; 222:149-155
43. Khalkhali I, Villanueva-Meyer J, Edell SL, et al. Diagnostic accuracy of 99mTc-sestamibi breast imaging: multicenter trial results. J Nucl Med 2000; 41:1973-1979 (Pubitemid 32038685)
44. Liberman M, Sampalis F, Mulder DS, Sampalis JS. Breast cancer diagnosis by scintimammography: a meta-analysis and review of the literature. Breast Cancer Res Treat 2003; 80:115-126 (Pubitemid 36851291)
45. Hruska CB, O'Connor MK. Nuclear imaging of the breast: translating achievements in instrumentation into clinical use. Med Phys 2013; 40:050901
46. Hruska CB, Phillips SW, Whaley DH, Rhodes DJ, O'Conner MK. Molecular breast imaging: use of dual-head dedicated gamma camera to detect small breast tumors. AJR 2008; 19:1805-1815
47. Brem RF, Floerke AC, Rapelyea JA, Teal C, Kelly T, Mathur V. Breast-specific gamma imaging as an adjunct imaging modality for the diagnosis of breast cancer. Radiology 2008; 247:651-657
48. Rhodes DJ, Hruska CB, Phillips SW, Whaley DH, O'Connor MK. Dedicated dual-head gamma imaging for breast cancer screening in women with mammographically dense breasts. Radiology 2011; 258:106-118
49. Hruska CB, Boughey JC, Phillips SW, et al. Scientific impact recognition award: molecular breast imaging - a review of the Mayo Clinic experience. Am J Surg 2008; 196:470-476
50. Hruska CB, Weinmann AL, Tello Skjersth CM, et al. Proof of concept for low-dose molecular breast imaging with dual-head CZT gamma camera. Part II. Evaluation in patients. Med Phys 2012; 39:3476-3483
51. Schilling K, Narayanan D, Kalinyak JE, et al. Positron emission mammography in breast cancer presurgical planning: comparisons with magnetic resonance imaging. Eur J Nucl Med Mol Imaging 2011; 38:23-36
52. Ohuchi N, Ishida T, Kawai M, Narikawa Y, Yamamoto S, Sobue T. Randomized controlled trial on effectiveness of ultrasonography screening for breast cancer in women aged 40-49 (J-START): research design. Jpn J Clin Oncol 2011; 41:275-277